The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance

Open Access

Peer-reviewed

Research Article

K. D. S. Fernald ,

* E-mail: kenneth.fernald@gmail.com

Affiliations Erasmus School of Economics, Applied Economics Department, Erasmus University, Rotterdam, Netherlands, VU University, Biology and Society Research Department (Athena Institute), Faculty of Earth and Life Sciences, Amsterdam, Netherlands
⨯
H. P. G. Pennings,

Affiliation Erasmus School of Economics, Applied Economics Department, Erasmus University, Rotterdam, Netherlands
⨯
J. F. van den Bosch,

Affiliation VU University, Biology and Society Research Department (Athena Institute), Faculty of Earth and Life Sciences, Amsterdam, Netherlands
⨯
H. R. Commandeur,

Affiliation Erasmus School of Economics, Applied Economics Department, Erasmus University, Rotterdam, Netherlands
⨯
E. Claassen

Affiliation VU University, Biology and Society Research Department (Athena Institute), Faculty of Earth and Life Sciences, Amsterdam, Netherlands
⨯

Reader Comments (0)

Biotechnology
Is the Subject Area "Biotechnology" applicable to this article?

Thanks for your feedback.
Drug interactions
Is the Subject Area "Drug interactions" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.
Drug discovery
Is the Subject Area "Drug discovery" applicable to this article?

Thanks for your feedback.
Platinum
Is the Subject Area "Platinum" applicable to this article?

Thanks for your feedback.
Data acquisition
Is the Subject Area "Data acquisition" applicable to this article?

Thanks for your feedback.
Drug dependence
Is the Subject Area "Drug dependence" applicable to this article?

Thanks for your feedback.
Finance
Is the Subject Area "Finance" applicable to this article?

Thanks for your feedback.